Clinical Trial Update: Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing gastrointestinal tolerability of mycophenolate mofetil (MMF) versus enteric-coated mycophenolate sodium (EC-MPS) in main…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplantation

Drugs mentioned

• EC-MPS (mycophenolate sodium)
• MMF (mycophenolate mofetil)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Organ Transplantation | Phase 4 | Status: UNKNOWN